Le Lézard
Classified in: Health
Subject: AVO

In New Ad Campaign, NACDS Calls on U.S. Congress to Pass "REAL REFORM" to Stop PBM Tactics Threatening Americans and Pharmacies


Pharmacists to Lawmakers: "If all patients don't benefit ... it's not real reform."

ARLINGTON, Va., Oct. 25, 2023 /PRNewswire-PRWeb/ -- The National Association of Chain Drug Stores (NACDS) today launched a new broadcast and digital advertising campaign to stress the need for true reform of pharmaceutical benefit manager (PBM) tactics ? so that Americans may benefit from lower drug prices and access to medications and to pharmacies. NACDS is emphasizing the particular focus that federal reform efforts must bring to protecting Americans on Medicare and Medicaid.

"PBM reform is needed now, and any proposed PBM legislation that does not include Americans served through Medicare and Medicaid ? and their pharmacies ? is not real reform."

"People must be at the center of care," said NACDS President and CEO Steven C. Anderson. "Americans should be able to go to any pharmacy and have access to their medicines at an affordable price. PBM reform is needed now, and any proposed PBM legislation that does not include Americans served through Medicare and Medicaid ? and their pharmacies ? is not real reform."

PBMs control Americans' access to often life-saving medications and they increase costs. Unpredictable and irrational "DIR fees" imposed on pharmacies have skyrocketed 107,400% over the past decade. Further, from 2014-2022, 1,357 medications were excluded from at least one PBM formulary for at least one year. The result is higher cost medications and less choice for patients.

"Pharmaceutical benefit manipulation" harms patients and pharmacies by driving up prices, limiting access to certain medications, and forcing pharmacies that serve their communities to close, especially in rural and underserved communities.

The national 30-second spot, titled 'REAL REFORM', addresses what U.S. Congress must do to stop abusive PBM tactics, while also strengthening oversight of PBMs, ensuring accountability, transparency, and fairness. The 'Real Reform' ad campaign will include broadcast, cable, web-based news, and digital executions.

NACDS, which represents national and regional pharmacies in the drug store, supermarket and mass retail settings, has been fighting on the frontline of this critical issue, urging federal and state leaders alike to protect patients from PBM tactics. The federal government has specific actions that are within its power and responsibility to accomplish to bring PBM reform to Medicare and Medicaid. Meanwhile, this year, NACDS has pushed for change at all levels of government and as a result, the enactment of 31 bills across 27 states led to 55 policy changes consistent with NACDS PBM reform and reimbursement priorities. This builds on the enactment of 101 state PBM reform bills combined in 2021 and 2022.

The full text of the 'REAL REFORM' 30-Second Ad is below:

You may be hearing a lot about pharmaceutical middlemen called PBMs.
As a pharmacist, I want to let you know why it matters.
For too long, these middlemen have
. . . pocketed savings that belong to you
. . . said 'no' to medicines you need
. . . and blocked you from your local pharmacist . . . like me
But Congress now has a chance to reduce drug costs ? and improve access . . . for ALL patients.
Including Americans on Medicare and Medicaid, who I serve every day.
Because let's be clear, if all patients don't benefit. . . it's not real reform.

To get more facts, go to NACDS' PBM reform web page.

Media Contact

Kathleen Bashur, NACDS, 703-837-4367, [email protected]https://www.nacds.org 

SOURCE NACDS


These press releases may also interest you

3 mai 2024
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

3 mai 2024
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

3 mai 2024
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

3 mai 2024
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

3 mai 2024
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

3 mai 2024
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: